PMID- 10514004 OWN - NLM STAT- MEDLINE DCOM- 19991026 LR - 20201219 IS - 1074-7613 (Print) IS - 1074-7613 (Linking) VI - 11 IP - 3 DP - 1999 Sep TI - The makings of a tumor rejection antigen. PG - 263-70 FAU - Gilboa, E AU - Gilboa E AD - Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA. e.gilboa@cgct.duke.edu LA - eng PT - Journal Article PT - Review PL - United States TA - Immunity JT - Immunity JID - 9432918 RN - 0 (Antigens, Neoplasm) RN - 0 (Cancer Vaccines) RN - 0 (Epitopes, T-Lymphocyte) SB - IM MH - Animals MH - Antigens, Neoplasm/*immunology MH - Cancer Vaccines/immunology MH - Epitopes, T-Lymphocyte/immunology MH - Humans MH - T-Lymphocytes, Cytotoxic/immunology MH - Vaccination RF - 80 EDAT- 1999/10/08 00:00 MHDA- 1999/10/08 00:01 CRDT- 1999/10/08 00:00 PHST- 1999/10/08 00:00 [pubmed] PHST- 1999/10/08 00:01 [medline] PHST- 1999/10/08 00:00 [entrez] AID - S1074-7613(00)80101-6 [pii] AID - 10.1016/s1074-7613(00)80101-6 [doi] PST - ppublish SO - Immunity. 1999 Sep;11(3):263-70. doi: 10.1016/s1074-7613(00)80101-6.